InvestorsHub Logo

NSX

Followers 164
Posts 8408
Boards Moderated 0
Alias Born 01/31/2018

NSX

Re: Rk3 post# 91471

Monday, 08/12/2019 5:51:10 PM

Monday, August 12, 2019 5:51:10 PM

Post# of 111071
$CELZ.....DD and $CELZ has an IP portfolio that is second to none!

$CELZ is a clinical stage Biotechnology now with revenues.
Q1 had 479% Revenue growth
Q2 is up next

Other variables include:

Clinical trials
Peer reviewed publication

other news

https://www.news-medical.net/news/20190805/FDA-announces-new-policy-framework-for-development-of-regenerative-medicine-products.aspx

FDA announces new policy framework for development of regenerative medicine products

Also this: Big Pharma is buying Stem Cell Biotech companies!

https://endpts.com/bayer-is-going-all-in-on-next-gen-stem-cell-biotech-bluerock-buying-out-versant-and-founders-for-600m/
Bayer is going all in on next-gen stem cell biotech BlueRock, buying out Versant and founders for $600M

http://www.finsmes.com/2019/08/bayer-acquires-bluerock-therapeutics-for-ev-of-usd1-billion.html


Ant the recent Newswire updated specifically mentioned this:

"Identify the correct strategic partner to commercialize the AmnioStem(R) platform. There has been interest from various parties and all opportunities will be considered."

This time it will be days not weeks

NSX


My research and my opinion. My opinions is not a recommendation to buy or sell a security. Your decision whether or not to make a purchase should be based on your own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News